| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | GSK1070916 | GDSC1000 | pan-cancer | AAC | -0.072 | 0.02 |
| mRNA | IPA-3 | GDSC1000 | pan-cancer | AAC | 0.075 | 0.02 |
| mRNA | VER-155008 | CTRPv2 | pan-cancer | AAC | -0.083 | 0.02 |
| mRNA | BRD-K66453893 | CTRPv2 | pan-cancer | AAC | -0.072 | 0.02 |
| mRNA | WZ3105 | GDSC1000 | pan-cancer | AAC | -0.067 | 0.02 |
| mRNA | OSI-930 | CTRPv2 | pan-cancer | AAC | -0.083 | 0.03 |
| mRNA | lenvatinib | CTRPv2 | pan-cancer | AAC | 0.082 | 0.03 |
| mRNA | Methotrexate | CTRPv2 | pan-cancer | AAC | -0.084 | 0.03 |
| mRNA | apicidin | CTRPv2 | pan-cancer | AAC | -0.069 | 0.03 |
| mRNA | UNC0638 | GDSC1000 | pan-cancer | AAC | -0.064 | 0.03 |